Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37898619)

  • 1. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy.
    Huang R; Wang Z; Hong J; Wu J; Huang O; He J; Chen W; Li Y; Chen X; Shen K
    Cell Death Dis; 2023 Oct; 14(10):703. PubMed ID: 37898619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3.
    Zhao C; Zeng N; Zhou X; Tan Y; Wang Y; Zhang J; Wu Y; Zhang Q
    BMC Cancer; 2023 May; 23(1):392. PubMed ID: 37127625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated adipocyte-derived G-CSF promotes breast cancer malignancy via Stat3 signaling.
    Liu L; Wu Y; Zhang C; Zhou C; Li Y; Zeng Y; Zhang C; Li R; Luo D; Wang L; Zhang L; Tu S; Deng H; Luo S; Chen YG; Xiong X; Yan X
    J Mol Cell Biol; 2020 Sep; 12(9):723-737. PubMed ID: 32242230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
    Tsai TH; Yang CC; Kou TC; Yang CE; Dai JZ; Chen CL; Lin CW
    J Cell Physiol; 2021 Jun; 236(6):4669-4680. PubMed ID: 33421130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
    Front Immunol; 2019; 10():757. PubMed ID: 31031757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.
    Lin C; He H; Liu H; Li R; Chen Y; Qi Y; Jiang Q; Chen L; Zhang P; Zhang H; Li H; Zhang W; Sun Y; Xu J
    Gut; 2019 Oct; 68(10):1764-1773. PubMed ID: 30661053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome.
    Gonzalez Suarez N; Fernandez-Marrero Y; Torabidastgerdooei S; Annabi B
    Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer.
    Li X; Tang L; Chen Q; Cheng X; Liu Y; Wang C; Zhu C; Xu K; Gao F; Huang J; Wang R; Guan X
    Chin Med J (Engl); 2022 Oct; 135(20):2436-2445. PubMed ID: 36583862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL8 induces M2 macrophage polarization and inhibits CD8
    Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
    FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.
    Liu Q; Dong HT; Zhao T; Yao F; Xu Y; Chen B; Wu Y; Jin F; Xing P
    Endocr Relat Cancer; 2022 Feb; 29(3):139-149. PubMed ID: 34935631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling.
    Wei X; Li S; He J; Du H; Liu Y; Yu W; Hu H; Han L; Wang C; Li H; Shi X; Zhan M; Lu L; Yuan S; Sun L
    Cell Commun Signal; 2019 Jun; 17(1):58. PubMed ID: 31170987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
    Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
    Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts.
    Wu Y; Yi Z; Li J; Wei Y; Feng R; Liu J; Huang J; Chen Y; Wang X; Sun J; Yin X; Li Y; Wan J; Zhang L; Huang J; Du H; Wang X; Li Q; Ren G; Li H
    Theranostics; 2022; 12(10):4564-4580. PubMed ID: 35832090
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
    Nie G; Cao X; Mao Y; Lv Z; Lv M; Wang Y; Wang H; Liu C
    Int Immunopharmacol; 2021 Jun; 95():107153. PubMed ID: 33677254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.